Stellar Biotechnologies gets immunotherapy manufacturing contract
Port Hueneme immunotherapy company Stellar Biotechnologies announced an exclusive multi-year supply agreement with Taiwanese manufacturer Amaran Biotechnology. The agreement coincides with late-stage clinical studies for an immunotherapy called Adagloxad Simolenin, which treats cancers including metastatic breast cancer. The two companies will also develop the manufacturing process for Stellar’s Keyhole Limpet Hemocyanin conjugated vaccine, made from Read More →
CalAmp misses analyst estimates for second quarter
CalAmp fell short of revenue and earnings per share estimates for the second quarter, the company reported Sept. 29. Net income was $521,000, which was down from $3.4 million in the second quarter of 2015. CalAmp posted revenues of $90.5 million, up from revenues of $69.8 million during the same quarter in 2015 but just Read More →
SEC warns firms about using non-GAAP numbers
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Calavo Growers reports highest quarterly net income in company history
Calavo Growers had its highest quarterly net income and gross profits ever, the company announced in a second quarter earnings report June 6, with earnings per diluted share of 56 cents. That beat the average estimate of analysts surveyed by Zacks Investment Research, which was for earnings of 50 cents per share. The Santa Paula-based Read More →
